ID
ALXA

Integral Derivatives’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Integral Derivatives’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50,000
Closed -$74K – 1560
2014
Q4 		$74K Hold
50,000
– – ﹤0.01% 1315
2014
Q3 		$116K Buy
+50,000
New +$191K ﹤0.01% 1319

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $445M AUM 42.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return